logotype
cat
dog
chameleon

EAG II includes representatives from stakeholder organizations, crucial for implementing any CALLISTO proposed actions. During the second cycle, this group focused on the selected paradigmatic diseases and analysed actions undertaken across Europe to prevent and control zoonoses transmitted by companion animals and gaps that might cause specific risks.

In particular the EAG II discussed and answered the following questions: are the selected 15 pathogens notifiable to ECDC or OIE/DG SANCO and which actions are taken at EU and country-level to monitor and control them? How current or proposed EU-legislation addresses these 15 pathogens and how well laws are implemented and followed by Member States? The group investigate also how is the collaboration and coordination between veterinary and human healthcare sectors in a One Health approach; policy actions effectiveness and specificity, according to different animal and human risk groups, were also addressed.

As concerns notifiable pathogens, of the 15 pathogens selected by CALLISTO, seven are notifiable to the OIE; nine are notifiable to ECDC and three both to OIE and ECDC. Two of them are not notifiable to ECDC or OIE. With reference to the legal background, EAG II summarized that EU legislation lays down general animal health requirements applicable to import and intra Community movement, including trade and non commercial movement. Regulation 998/2003 is the only specific legislation in EU on companion animal diseases (it covers rabies in cats, dogs and ferrets). The EU Commission’ s proposal for a Community Health Regulation was also analysed.

Read the “Strategy Report – 2nd Cycle” , chapter III to learn more about EAG II activities and findings for this second year of CALLISTO research.